Showing results (161-170 of 235) with videos related to
Sort By:
Pageof 24
European Journal of Radiology|August 2, 2025
MRI-based radiomics predicts the pathologic response of colorectal liver metastases to systemic therapy: A multicenter studyAngela Ammirabile, Riccardo Levi, Luca Boldrini, et al.Oncogene|October 9, 2019
Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variantVeronica Veschi, Laura R Mangiapane, Annalisa Nicotra, et al.Surgery|February 24, 2021
Liver resection for perihilar cholangiocarcinoma: Impact of biliary drainage failure on postoperative outcome. Results of an Italian multicenter studyFelice Giuliante, Francesco Ardito, Luca Aldrighetti, et al.Annals of Surgery|May 27, 2017
RAS Mutation Clinical Risk Score to Predict Survival After Resection of Colorectal Liver MetastasesKristoffer W Brudvik, Robert P Jones, Felice Giuliante, et al.Annals of Surgical Oncology|March 5, 2021
Conditional Recurrence-Free Survival after Oncologic Extended Resection for Gallbladder Cancer: An International Multicenter AnalysisEduardo A Vega, Timothy E Newhook, Yoshikuni Kawaguchi, et al.World Journal of Hepatology|January 24, 2018
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinomaFrancesca Romana Ponziani, Irene Spinelli, Emanuele Rinninella, et al.Cancers|September 9, 2023
Radiomic Analysis of Intrahepatic Cholangiocarcinoma: Non-Invasive Prediction of Pathology Data: A Multicenter Study to Develop a Clinical-Radiomic ModelFrancesco Fiz, Noemi Rossi, Serena Langella, et al.Annals of Surgical Oncology|May 26, 2024
Radiomics of Intrahepatic Cholangiocarcinoma and Peritumoral Tissue Predicts Postoperative Survival: Development of a CT-Based Clinical-Radiomic ModelFrancesco Fiz, Noemi Rossi, Serena Langella, et al.Hepatology (Baltimore, Md.)|September 26, 2020
DCLK1, a Putative Stem Cell Marker in Human CholangiocarcinomaLorenzo Nevi, Sabina Di Matteo, Guido Carpino, et al.Tumori|April 11, 2019
The Italian Rare Pancreatic Exocrine Cancer InitiativeOronzo Brunetti, Claudio Luchini, Antonella Argentiero, et al.Pageof 24